Alcohol
Volume 22, Issue 3 , Pages 165-171 , November 2000

Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain

  • Sara Lindholm

      Affiliations

    • Clinical Alcohol and Drug Addiction Research, Department of Clinical Neuroscience, Magnus Huss, M4:02, Karolinska Hospital, Karolinska Institutet, SE-171 76 Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46-8-51774870; fax: +46-8-326369
    • ,
  • Karolina Ploj

      Affiliations

    • Department of Pharmaceutical Biosciences, Division of Pharmacology, Uppsala University, Uppsala, Sweden
    • ,
  • Johan Franck

      Affiliations

    • Clinical Alcohol and Drug Addiction Research, Department of Clinical Neuroscience, Magnus Huss, M4:02, Karolinska Hospital, Karolinska Institutet, SE-171 76 Stockholm, Sweden
    • ,
  • Ingrid Nylander

      Affiliations

    • Department of Pharmaceutical Biosciences, Division of Pharmacology, Uppsala University, Uppsala, Sweden

Received 31 January 2000 ,Revised 5 July 2000 ,Accepted 17 August 2000.

References 

  1. Anden NE, Dahlstrom A, Fuxe K, Olson L, Ungerstedt U. Ascending noradrenaline neurons from the pons and the medulla oblongata. Experientia. 1966;22:44–45
  2. Anokhina IP. Neurochemical aspects in pathogenesis of alcohol and drug dependence. Drug Alcohol Depend. 1979;4:265–273
  3. Bals-Kubik R, Herz A, Shippenberg TS. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology. 1989;98:203–206
  4. Bandler R, Shipley MT. Columnar organization in the midbrain periaqueductal gray: modules for emotional expression?. Trends Neurosci. 1994;17:379–389
  5. Bergstrom L, Christensson I, Folkesson R, Stenstrom B, Terenius L. An ion exchange chromatography and radioimmunoassay procedure for measuring opioid peptides and substance P. Life Sci. 1983;33:1613–1619
  6. Bloom F, Lad P, Pittman Q, Rogers J. Blood alcohol levels in rats: non-uniform yields from intraperitoneal doses based on body weight. Br J Pharmacol. 1982;75:251–254
  7. Brandao ML. Involvement of opioid mechanisms in the dorsal periaqueductal gray in drug abuse. Rev Neurosci. 1993;4:397–405
  8. Chieng B, Christie MD. Local opioid withdrawal in rat single periaqueductal gray neurons in vitro. J Neurosci. 1996;16:7128–7136
  9. Christensson-Nylander I, Nyberg F, Ragnarsson U, Terenius L. A general procedure for analysis of proenkephalin B derived opioid peptides. Regul Pept. 1985;11:65–76
  10. Christensson-Nylander I, Herrera-Marschitz M, Staines W, Hokfelt T, Terenius L, Ungerstedt U, et al. Striato-nigral dynorphin and substance P pathways in the rat: I. Biochemical and immunohistochemical studies. Exp Brain Res. 1986;64:169–192
  11. Dahlström A, Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system: I. Demonstration of monoamine-containing neurons in the cell bodies of brainstem neurons. Acta Physiol Scand. 1964;62(suppl. 232):1
  12. DeJong RN. The hippocampus and its role in memory. Clinical manifestations and theoretical considerations. J Neurol Sci. 1973;19:73–83
  13. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain. 1995;118:279–306
  14. de Waele JP, Gianoulakis C. Enhanced activity of the brain beta-endorphin system by free-choice ethanol drinking in C57BL/6 but not DBA/2 mice. Eur J Pharmacol. 1994;258:119–129
  15. de Waele JP, Gianoulakis C. Characterization of the mu and delta opioid receptors in the brain of the C57BL/6 and DBA/2 mice selected for their differences in voluntary ethanol consumption. Alcohol: Clin Exp Res. 1997;21:754–762
  16. de Waele JP, Kiianmaa K, Gianoulakis C. Distribution of the mu and delta opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats. J Pharmacol Exp Ther. 1995;275:518–527
  17. Di Chiara G, Imperato A. Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur J Pharmacol. 1985;115:131–132
  18. Di Chiara G, Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther. 1988;244:1067–1080
  19. Dykstra LA, Preston KL, Bigelow GE. Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects. Psychopharmacology (Berlin). 1997;130:14–27
  20. Eriksson K. Genetic selection for voluntary alcohol consumption in the albino rat. Science. 1968;159:739–741
  21. Franck J, Lindholm S, Raaschou P. Modulation of volitional ethanol intake in the rat by central delta-opioid receptors. Alcohol: Clin Exp Res. 1998;22:1185–1189
  22. Froehlich JC, Harts J, Lumeng L, Li TK. Naloxone attenuation of voluntary alcohol consumption. Alcohol Alcohol. 1987;333–337suppl.
  23. Froehlich JC, Zweifel M, Harts J, Lumeng L, Li TK. Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology. 1991;103:467–472
  24. Fukunaga Y, Nishida S, Inoue N, Miyamoto M, Kishioka S, Yamamoto H. Time course of morphine withdrawal and preproenkephalin gene expression in the periaqueductal gray of rats. Brain Res Mol Brain Res. 1998;55:221–231
  25. Gentry RT. An experimental model of self-intoxication in C57 mice. Alcohol. 1985;2:671–675
  26. Haffmans J, Dzoljic MR. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms. Gen Pharmacol. 1987;18:103–105
  27. Herrera-Marschitz M, Christensson-Nylander I, Sharp T, Staines W, Reid M, Hokfelt T, et al. Striato-nigral dynorphin and substance P pathways in the rat: II. Functional analysis. Exp Brain Res. 1986;64:193–207
  28. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berlin). 1997;129:99–111
  29. Honkanen A, Vilamo L, Wegelius K, Sarviharju M, Hyytia P, Korpi ER. Alcohol drinking is reduced by a mu 1− but not by a delta-opioid receptor antagonist in alcohol-preferring rats. Eur J Pharmacol. 1996;304:7–13
  30. Hyytia P. Involvement of mu-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol, Biochem Behav. 1993;45:697–701
  31. Jamensky NT, Gianoulakis C. Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice. Alcohol: Clin Exp Res. 1997;21:1455–1464
  32. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 1997;278:52–58
  33. Koob GF, Vaccarino FJ, Amalric M, Bloom FE. Neurochemical substrates for opiate reinforcement. NIDA Res Monogr. 1986;71:146–164
  34. Krishnan-Sarin S, Wand GS, Li XW, Portoghese PS, Froehlich JC. Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking. Pharmacol, Biochem Behav. 1998;59:627–635
  35. Li TK, Lumeng L, McBride WJ, Waller MB. Progress toward a voluntary oral consumption model of alcoholism. Drug Alcohol Depend. 1979;4:45–60
  36. Li TK, Lumeng L, McBride WJ, Murphy JM, Froehlich JC, Morzorati S. Pharmacology of alcohol preference in rodents. Adv Alcohol Subst Abuse. 1988;7:73–86
  37. Li YQ, Rao ZR, Shi JW. Midbrain periaqueductal gray neurons with substance P- or enkephalin-like immunoreactivity send projection fibers to the nucleus accumbens in the rat. Neurosci Lett. 1990;119:269–271
  38. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci. 1987;7:2445–2464
  39. McGinty JF, Henriksen SJ, Goldstein A, Terenius L, Bloom FE. Opioid peptide identity and localization in hippocampus. Life Sci. 1982;31:1797–1800
  40. Nylander I, Hyytia P, Forsander O, Terenius L. Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems. Alcohol: Clin Exp Res. 1994;18:1272–1279
  41. Nylander I, Stenfors C, Tan-No K, Mathe AA, Terenius L. A comparison between microwave irradiation and decapitation: basal levels of dynorphin and enkephalin and the effect of chronic morphine treatment on dynorphin peptides. Neuropeptides. 1997;31:357–365
  42. Paxinos S, Watson C. The Rat Brain Atlas in Stereotaxic Coordinates. London: Academic Press; 1986;
  43. Ploj K, Roman E, Gustafsson L, Nylander I. Basal levels and alcohol induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice. Brain Res Bull. 2000;in press
  44. Przewlocka B, Lason W, Przewlocki R. Repeated ethanol administration decreases prodynorphin biosynthesis in the rat hippocampus. Neurosci Lett. 1992;134:195–198
  45. Przewlocka B, Turchan J, Lason W, Przewlocki R. Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens. Neurosci Lett. 1997;238:13–16
  46. Reader TA, Grondin L. Distribution of catecholamines, serotonin, and their major metabolites in the rat cingulate, piriform-entorhinal, somatosensory, and visual cortex: a biochemical survey using high-performance liquid chromatography. Neurochem Res. 1987;12:1087–1097
  47. Rosin Å, Lindholm S, Franck J, Georgieva J. Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens. Neurosci Lett. 1999;275:1–4
  48. Seizinger BR, Bovermann K, Maysinger D, Hollt V, Herz A. Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary. Pharmacol, Biochem Behav. 1983;18:361–369
  49. Simmons ML, Chavkin C. Endogenous opioid regulation of hippocampal function. Int Rev Neurobiol. 1996;39:145–196
  50. Spanagel R, Herz A, Shippenberg TS. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem. 1990;55:1734–1740
  51. Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA. 1992;89:2046–2050
  52. Stromberg MF, Casale M, Volpicelli L, Volpicelli JR, O'Brien CP. A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat. Alcohol. 1998;15:281–289
  53. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand, Suppl. 1971;367:1–48
  54. Unterwald EM, Rubenfeld JM, Kreek MJ. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. NeuroReport. 1994;5:1613–1616
  55. Watson SJ, Khachaturian H, Akil H, Coy DH, Goldstein A. Comparison of the distribution of dynorphin systems and enkephalin systems in brain. Science. 1982;218:1134–1136
  56. You ZB, Herrera-Marschitz M, Nylander I, Goiny M, O'Connor WT, Ungerstedt U, et al. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis: II. Effects of dopamine D1 and D2 receptor agonists. Neuroscience. 1994;63:427–434

PII: S0741-8329(00)00118-X

Alcohol
Volume 22, Issue 3 , Pages 165-171 , November 2000

Article Tools

* Image Usage & Resolution